Outset Medical Inc (OM) last year’s performance of -83.28% is a clear signal for an entertaining trading season.

SQ

On Tuesday, Outset Medical Inc (NASDAQ: OM) opened lower -4.72% from the last session, before settling in for the closing price of $1.06. Price fluctuations for OM have ranged from $0.44 to $6.36 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 202.67%. Company’s average yearly earnings per share was noted 25.83% at the time writing. With a float of $48.26 million, this company’s outstanding shares have now reached $52.54 million.

Let’s determine the extent of company efficiency that accounts for 480 employees. In terms of profitability, gross margin is 30.97%, operating margin of -112.32%, and the pretax margin is -122.32%.

Outset Medical Inc (OM) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Outset Medical Inc is 8.14%, while institutional ownership is 48.61%. The most recent insider transaction that took place on Nov 15 ’24, was worth 4,516. In this transaction Chair and CEO of this company sold 5,645 shares at a rate of $0.80, taking the stock ownership to the 904,851 shares. Before that another transaction happened on Nov 15 ’24, when Company’s SVP Operations and R&D sold 1,375 for $0.80, making the entire transaction worth $1,100. This insider now owns 238,022 shares in total.

Outset Medical Inc (OM) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 25.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.80% during the next five years compared to -15.08% drop over the previous five years of trading.

Outset Medical Inc (NASDAQ: OM) Trading Performance Indicators

Check out the current performance indicators for Outset Medical Inc (OM). In the past quarter, the stock posted a quick ratio of 5.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.46.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.77, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -1.48 in one year’s time.

Technical Analysis of Outset Medical Inc (OM)

Looking closely at Outset Medical Inc (NASDAQ: OM), its last 5-days average volume was 0.51 million, which is a drop from its year-to-date volume of 1.3 million. As of the previous 9 days, the stock’s Stochastic %D was 36.88%. Additionally, its Average True Range was 0.12.

During the past 100 days, Outset Medical Inc’s (OM) raw stochastic average was set at 16.59%, which indicates a significant decrease from 34.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 130.96% in the past 14 days, which was lower than the 215.66% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.7981, while its 200-day Moving Average is $2.0917. However, in the short run, Outset Medical Inc’s stock first resistance to watch stands at $1.0729. Second resistance stands at $1.1357. The third major resistance level sits at $1.1915. If the price goes on to break the first support level at $0.9543, it is likely to go to the next support level at $0.8985. Now, if the price goes above the second support level, the third support stands at $0.8357.

Outset Medical Inc (NASDAQ: OM) Key Stats

There are currently 52,542K shares outstanding in the company with a market cap of 53.07 million. Presently, the company’s annual sales total 130,380 K according to its annual income of -172,800 K. Last quarter, the company’s sales amounted to 28,670 K and its income totaled -27,940 K.